Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Gastric Cancer

  Free Subscription

Articles published in Dig Dis

Retrieve available abstracts of 8 articles:
HTML format

Single Articles

    February 2020
  1. PETRYSZYN P, Chapelle N, Matysiak-Budnik T
    Gastric cancer: Where are we heading?
    Dig Dis. 2020 Feb 17. pii: 000506509. doi: 10.1159/000506509.
    PubMed     Abstract available

  2. MIZUTANI T, Araki H, Saigo C, Takada J, et al
    Endoscopic and Pathological Characteristics of Helicobacter pylori Infection-Negative Early Gastric Cancer.
    Dig Dis. 2020 Feb 11:1-10. doi: 10.1159/000506120.
    PubMed     Abstract available

    May 2019
  3. ESAKI M, Hatta W, Shimosegawa T, Oyama T, et al
    Age Affects Clinical Management after Noncurative Endoscopic Submucosal Dissection for Early Gastric Cancer.
    Dig Dis. 2019 May 16:1-11. doi: 10.1159/000499538.
    PubMed     Abstract available

    January 2019
  4. KANG SH, Moon HS, Sung JK, Jeong HY, et al
    Endoscopic Prediction of Tumor Invasion Depth in Early Gastric Signet Ring Cell Carcinoma.
    Dig Dis. 2019;37:201-207.
    PubMed     Abstract available

  5. SIMIC AP, Skrobic OM, Pesko PM
    A Surgeon's Role in the Management of Early Esophageal, EGJ and Gastric Lesions.
    Dig Dis. 2019;37:355-363.
    PubMed     Abstract available

  6. BORNSCHEIN J, Bird-Lieberman EL, Malfertheiner P
    The Rationale and Efficacy of Primary and Secondary Prevention in Adenocarcinomas of the Upper Gastrointestinal Tract.
    Dig Dis. 2019;37:381-393.
    PubMed     Abstract available

    June 2018
  7. LIATSOS C, Rokkas T
    The Effect of Chronic Use of Proton Pump Inhibitors on Gastric Cancer: Should We Be Aware of It?
    Dig Dis. 2018 Jun 6:1-2. doi: 10.1159/000489629.

  8. JOO MK, Park JJ, Chun HJ
    Response to the Editorial: The Effect of Chronic Use of Proton Pump Inhibitors on Gastric Cancer.
    Dig Dis. 2018 Jun 6:1-2. doi: 10.1159/000490109.

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.